0000908662-20-000031.txt : 20200211
0000908662-20-000031.hdr.sgml : 20200211
20200211160225
ACCESSION NUMBER: 0000908662-20-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200207
FILED AS OF DATE: 20200211
DATE AS OF CHANGE: 20200211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CGI Cellerate RX, LLC
CENTRAL INDEX KEY: 0001766396
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 20596496
BUSINESS ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
BUSINESS PHONE: 512-320-8600
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Catalyst Rochal, LLC
CENTRAL INDEX KEY: 0001766398
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 20596497
BUSINESS ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
BUSINESS PHONE: 512-320-8600
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gurasich Bradley J.
CENTRAL INDEX KEY: 0001766399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11808
FILM NUMBER: 20596498
MAIL ADDRESS:
STREET 1: C/O THE CATALYST GROUP, INC.
STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220
CITY: AUSTIN
STATE: TX
ZIP: 78735
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sanara MedTech Inc.
CENTRAL INDEX KEY: 0000714256
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 592220004
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817-529-2300
MAIL ADDRESS:
STREET 1: 1200 SUMMIT AVE
STREET 2: SUITE 414
CITY: FORT WORTH
STATE: TX
ZIP: 76102
FORMER COMPANY:
FORMER CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC.
DATE OF NAME CHANGE: 20080611
FORMER COMPANY:
FORMER CONFORMED NAME: MB SOFTWARE CORP
DATE OF NAME CHANGE: 19960805
FORMER COMPANY:
FORMER CONFORMED NAME: INAV TRAVEL CORPORATION
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-02-07
0000714256
Sanara MedTech Inc.
SMTI
0001766396
CGI Cellerate RX, LLC
1375 ENCLAVE BOULEVARD
HOUSTON
TX
77077
0
0
1
0
0001766398
Catalyst Rochal, LLC
1375 ENCLAVE BOULEVARD
HOUSTON
TX
77077
0
0
1
0
0001766399
Gurasich Bradley J.
7500 RIALTO BLVD., BUILDING II
SUITE 220
AUSTIN
TX
78735
0
0
1
0
Common Stock
2020-02-07
4
C
0
2273630
A
2273630
D
Common Stock
2020-02-07
4
C
0
179101
9
A
2452731
D
Series F Convertible Preferred Stock
2020-02-07
4
C
0
1136815
D
Common Stock
2273630
0
D
5% Convertible Promissory Note
9
2020-02-07
4
C
0
1611911
D
2019-08-28
2021-03-01
Common Stock
179101
0
D
The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock.
Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.
The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share.
CGI CELLERATE RX, LLC, by /s/ Ron Nixon and /s/ Brad Gurasich
2020-02-11
CATALYST ROCHAL, LLC, by /s/ Ron Nixon and /s/ Brad Gurasich
2020-02-11
/s/ Brad Gurasich
2020-02-11